Evidence map›Paper›PMID 35442770›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2022

Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty.

Corine Ghosn, Lakshmi Rajagopalan, Sveti Ugarte, Shruti Mistry, Werhner Orilla, Margot L Goodkin, Michael R Robinson, Michael Engles, Mohammed Dibas

Open access · hybridAbstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2024
    Article
  3. From Eye Care to Hair Growth: Bimatoprost.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Glaucoma Animal Models beyond Chronic IOP Increase.International journal of molecular sciences · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Corine GhosnAllergan, An AbbVie Company, Irvine, California, USA.
Lakshmi RajagopalanAllergan, An AbbVie Company, Irvine, California, USA.
Sveti UgarteAllergan, An AbbVie Company, Irvine, California, USA.
Shruti MistryAllergan, An AbbVie Company, Irvine, California, USA.
Werhner OrillaAllergan, An AbbVie Company, Irvine, California, USA.
Margot L GoodkinAllergan, An AbbVie Company, Irvine, California, USA.
Michael R RobinsonAllergan, An AbbVie Company, Irvine, California, USA.
Michael EnglesAllergan, An AbbVie Company, Irvine, California, USA.
Mohammed DibasAllergan, An AbbVie Company, Irvine, California, USA.
Allergan (Ireland) · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Laser TherapyOcular HypertensionTrabeculectomyAnimalsBimatoprostDelayed-Action PreparationsDogsIntraocular PressureLasersTreatment OutcomeBimatoprostDelayed-Action Preparationsbimatoprostglaucomaintraocular pressurelaser trabeculoplastyocular hypertensionsustained-release implant

Identifiers

PMID35442770
PMCPMC9125576
OpenAlexW4224270702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.